NDC Package 60687-127-65 Omega-3-acid Ethyl Esters

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

60687-127-65

Package Description:

50 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (60687-127-11)

Product Code:

60687-127

Proprietary Name:

Omega-3-acid Ethyl Esters

Usage Information:

Omega-3-acid ethyl esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG). Omega-3-acid ethyl esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG). Patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, USP and should continue this diet during treatment with omega-3-acid ethyl esters capsules, USP. Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, USP and should continue this diet during treatment with omega-3-acid ethyl esters capsules, USP. Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. Medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. Medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. Limitations of Use: The effect of omega-3-acid ethyl esters capsules, USP on the risk for pancreatitis has not been determined.The effect of omega-3-acid ethyl esters capsules, USP on cardiovascular mortality and morbidity has not been determined.The effect of omega-3-acid ethyl esters capsules, USP on cardiovascular mortality and morbidity has not been determined.

11-Digit NDC Billing Format:

60687012765

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

50 EA

Labeler Name:

American Health Packaging

Sample Package:

FDA Application Number:

ANDA090973

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

10-13-2016

End Marketing Date:

04-30-2025

Listing Expiration Date:

04-30-2025

Exclude Flag:

Code Structure:

60687 - American Health Packaging
- 60687-127 - Omega-3-acid Ethyl Esters
  - 60687-127-65 - 50 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (60687-127-11)

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 60687-127-65?

The NDC Packaged Code 60687-127-65 is assigned to a package of 50 blister pack in 1 box, unit-dose / 1 capsule, liquid filled in 1 blister pack (60687-127-11) of Omega-3-acid Ethyl Esters, labeled by American Health Packaging. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 50 billable units per package.

Is NDC 60687-127 included in the NDC Directory?

No, Omega-3-acid Ethyl Esters with product code 60687-127 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by American Health Packaging on October 13, 2016 and its listing in the NDC Directory is set to expire on April 30, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 60687-127-65?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 50.

What is the 11-digit format for NDC 60687-127-65?

The 11-digit format is 60687012765. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	60687-127-65	5-4-2	60687-0127-65

Table of Contents